๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Rapid Dose Therapeutics Corp. (CSE:DOSE)
Canada flag Canada ยท Delayed Price ยท Currency is CAD
0.0950
+0.0050 (5.56%)
Nov 20, 2026, 3:12 PM EST

Rapid Dose Therapeutics Financials Overview

Millions CAD. Fiscal year is Mar - Feb.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
Revenue
2.122.772.091.020.721.75
Revenue Growth
-19.31%33.00%104.34%42.06%-59.00%131.98%
Gross Profit
1.041.361.180.560.361.34
Operating Income
-1.88-2.17-4.17-3.09-3.54-4.3
Net Income
-3.14-3.39-5.4-4.31-3.81-8.49
Earnings Per Share
-0.02-0.03-0.04-0.04-0.04-0.08
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
Cash & Investments
0.010.010.020.160.030.03
Total Debt
5.885.322.612.452.121.43
Net Cash (Debt)
-5.87-5.31-2.59-2.29-2.1-1.4
Net Cash Growth
------
Net Cash Per Share
-0.04-0.04-0.02-0.02-0.02-0.01

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
Operating Cash Flow
0.62-0.27-1.15-2.29-0.86-3
Capital Expenditures
--0-0.01---0.04
Free Cash Flow
0.62-0.27-1.15-2.29-0.86-3.04
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
Gross Margin
49.12%49.15%56.59%55.21%49.67%76.76%
Operating Margin
-88.50%-78.29%-200.07%-302.45%-493.36%-245.55%
Pretax Margin
-148.27%-122.22%-259.18%-422.03%-530.42%-484.47%
Profit Margin
-148.28%-122.23%-259.18%-422.03%-530.42%-484.47%
FCF Margin
29.09%-9.78%-55.27%-224.91%-120.27%-173.52%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
PS Ratio
6.187.3110.5620.2012.9815.10